Neonatal hypoxic-ischemic encephalopathy, commonly known as HIE, can develop before, during or shortly after birth. Reduced oxygen delivery disrupts the brain’s energy supply, impairing the production of adenosine triphosphate, the molecule cells use to power essential functions. When energy reserves collapse, neurons lose the ability to maintain their electrical gradients, cellular membranes become unstable and a cascade of biochemical events can trigger inflammation, oxidative stress and cell death. The initial injury may be followed hours later by a secondary phase of damage, making rapid diagnosis and intervention critical.

For eligible infants with moderate to severe HIE, therapeutic hypothermia is currently a principal treatment. The newborn’s body temperature is carefully lowered, typically for 72 hours, before being gradually rewarmed. Cooling slows metabolism and may limit the secondary injury cascade, improving the chances of survival without severe disability. Yet even with advances in neonatal intensive care, the outcomes remain highly variable. Some children develop cerebral palsy, epilepsy, learning difficulties, visual or hearing problems, behavioral differences or cognitive impairments, while others show relatively few long-term effects. Families are often left navigating this uncertainty from the first hours of their child’s life.

The article emphasizes that the medical emergency does not end when the infant leaves the neonatal intensive care unit. HIE can influence development over many years, and the challenges may change as a child grows. Early motor problems can later be accompanied by difficulties with language, memory, attention, executive function or social interaction. Standard neurological examinations and developmental assessments may not capture the full impact on daily life. Parents frequently become the first to notice subtle changes, identify barriers to care and coordinate appointments across multiple specialties, giving them a unique perspective that can strengthen both diagnosis and follow-up.

According to the authors, meaningful family engagement requires more than asking parents to sign consent forms or complete questionnaires. Families should be involved in deciding which research questions matter most, designing studies, interpreting findings and determining how results are communicated. Their experiences can reveal outcomes that researchers might otherwise overlook, including sleep disruption, transportation difficulties, financial stress, limited access to rehabilitation and the emotional consequences of living with an uncertain prognosis. These details are not peripheral to clinical science; they help define whether a treatment or care pathway genuinely improves a child’s life.

The call also highlights the importance of communication during the first days after birth. Parents of infants with HIE may be confronted with complex explanations about brain imaging, seizures, cooling protocols and possible outcomes while coping with fear, exhaustion and shock. Technical accuracy must be matched with clarity and compassion. Clinicians may need to explain that magnetic resonance imaging can show patterns of injury but cannot always predict an individual child’s future with certainty. Similarly, the absence of obvious early symptoms does not guarantee that later developmental concerns will never emerge. Families need information that is honest, understandable and revisited over time.

Seizures are a particular concern in HIE because abnormal electrical activity can further stress an already injured brain. Many seizures in newborns are clinically silent, meaning they can be detected only through electroencephalography, or EEG. This makes continuous brain monitoring an important part of care in many intensive care settings. However, the article’s family-centered approach underscores that clinical decisions should also consider the experiences and priorities of caregivers. Parents may need help understanding why monitoring is necessary, what treatments can and cannot achieve, and how short-term interventions relate to longer-term neurological development.

The authors further call for research systems that include families who are often underrepresented. Language barriers, cultural differences, disability, poverty, geographic isolation and unequal access to specialized hospitals can all affect whether families participate in studies or receive consistent follow-up. If research includes only those with the time, resources and confidence to engage with academic institutions, its conclusions may not reflect the wider population of children with HIE. More inclusive approaches could involve flexible appointments, remote participation, translated materials, compensation for time and travel, and partnerships with parent-led organizations.

This shift could also accelerate the development of better outcome measures. Traditional studies often focus on survival, major disability or standardized developmental scores. Families may define success more broadly: the ability to communicate, attend school, form relationships, sleep independently, participate in play or manage everyday activities with appropriate support. Bringing these priorities into clinical trials could produce a more complete picture of whether an intervention works. It may also encourage researchers to study quality of life, caregiver well-being and the effectiveness of long-term rehabilitation alongside brain imaging and neurological examinations.

The message from Pilon, Cavaller-Bellaubi, Daly and their colleagues is ultimately both scientific and societal: families possess essential knowledge about HIE, and neonatal medicine cannot reach its full potential without it. By treating parents as partners rather than observers, healthcare professionals and researchers can improve communication, identify overlooked needs and design services that follow children beyond the intensive care unit. For families confronting one of the most frightening emergencies in newborn medicine, participation is not simply an invitation to be heard. It is a route toward care that is more accurate, more humane and better aligned with the realities of life after neonatal brain injury.

Subject of Research: Family engagement in neonatal hypoxic-ischemic encephalopathy care and research

Article Title: Engaging families with experience of neonatal hypoxic ischemic encephalopathy: a call to action

Article References: Pilon, B., Cavaller-Bellaubi, M., Daly, M. et al. “Engaging families with experience of neonatal hypoxic ischemic encephalopathy: a call to action.” Pediatric Research (2026). https://doi.org/10.1038/s41390-026-05329-1

Image Credits: AI Generated

DOI: 10.1038/s41390-026-05329-1

Keywords: neonatal hypoxic-ischemic encephalopathy, HIE, neonatal brain injury, therapeutic hypothermia, family engagement, neonatal intensive care, neurodevelopment, pediatric research, brain injury, parent participation

This study rigorously examined neonates suffering from HIE with a particular focus on the incidence and predictors of acute kidney injury. Utilizing two distinct classification systems—the Kidney Disease: Improving Global Outcomes (KDIGO) and the Gupta definitions—the researchers sought to delineate AKI more precisely within this vulnerable population. Such dual-framework analysis provides an unprecedented level of detail, addressing the diagnostic ambiguities that have historically hampered understanding in neonatal AKI associated with encephalopathy.

The pathophysiology underlying AKI in the context of HIE is complex and multifactorial. Perinatal asphyxia results in systemic hypoxia and ischemia, which disrupt renal perfusion and precipitate direct tubular injury. Furthermore, the systemic inflammatory cascade triggered by hypoxic insults exacerbates the damage, perpetuating kidney dysfunction. However, the exact clinical and biochemical markers predictive of AKI development in HIE infants remained unclear until this thorough investigation.

From a cohort of neonates admitted with HIE, the study meticulously evaluated those who developed AKI according to both the KDIGO and Gupta criteria. This comparative approach not only enriched the sensitivity of AKI detection but also underscored discrepancies and potential limitations inherent in each definitional framework. The findings revealed a significant prevalence of AKI in HIE patients, profoundly impacting their immediate clinical trajectory.

One of the novel elements of the research was its detailed analysis of risk factors for AKI in the context of neonatal HIE. Contrary to earlier assumptions that solely severe hypoxic injury predicted kidney complications, the authors identified a constellation of variables including gestational age, birth weight, the severity of encephalopathy, and specific biochemical parameters that robustly correlated with heightened AKI risk. This multidimensional risk profiling opens avenues for earlier identification and tailored clinical interventions aimed at renal protection.

The implications of these findings resonate far beyond the neonatal intensive care unit. Acute kidney injury in newborns is not merely a transient aberration of renal function; it can herald chronic kidney disease and hypertension later in life. Recognizing AKI early in HIE newborns, therefore, is not only critical for immediate management but also for strategizing long-term follow-up and care to mitigate future renal morbidity.

Perhaps one of the most compelling contributions of this study lies in its longitudinal assessment of kidney outcomes post-hospitalization. By following neonates with HIE-associated AKI over an extended period, the researchers documented persistent renal impairment in a significant proportion, reinforcing the argument for vigilant ongoing surveillance. This long-term perspective challenges the traditional notion of neonatal AKI as a reversible and self-limited event.

Technical innovations employed in this research include the integration of advanced biomarker analysis alongside conventional serum creatinine measurements. These biomarkers, including novel urinary proteins indicative of tubular damage, enhanced the resolution of AKI diagnosis and provided early warnings even before overt clinical signs appeared. This underscores a paradigm shift toward precision medicine in neonatal care, where molecular diagnostics augment traditional clinical assessments.

Additionally, the study emphasized the limitations of relying solely on serum creatinine criteria, especially in neonates where maternal creatinine influence and low muscle mass confound readings. By applying the Gupta definition, which incorporates urine output and alternative biochemical markers, the authors demonstrated improved accuracy in AKI diagnosis, advocating for broader adoption of such comprehensive criteria in clinical practice.

Beyond diagnostics, the research also touched upon therapeutic implications. The correlation between AKI development and adverse neurologic outcomes in HIE suggests that renal injury may not merely be a bystander but an active participant in systemic disease progression. This insight propels the argument for integrative care approaches that address both brain and kidney protection simultaneously, potentially through modulating inflammatory pathways and optimizing fluid management.

Furthermore, the study challenges clinicians and researchers to reconsider current protocols in neonatal units, emphasizing the necessity for standardized AKI screening in all HIE patients. The authors propose that early detection coupled with supportive renal care could improve mortality and morbidity outcomes, although they acknowledge the need for randomized trials to establish definitive interventions.

From a broader scientific perspective, this work fills a critical gap in neonatal renal medicine, offering a robust dataset that informs future research directions. It paves the way for exploring mechanistic pathways linking cerebral hypoxia to renal tubular injury, potentially identifying novel therapeutic targets. Moreover, it highlights the importance of multidisciplinary collaboration in managing complex neonatal syndromes.

In summary, the study by Todo Bom Costa and colleagues represents a significant leap forward in neonatal care by elucidating the risk factors and outcomes of AKI in neonates with hypoxic ischemic encephalopathy. Their use of dual diagnostic criteria, comprehensive risk assessment, and long-term follow-up redefines how clinicians understand and approach renal complications in this fragile population. The findings not only underscore the clinical necessity for vigilant kidney monitoring but also ignite hope for improved strategies to safeguard the renal health of the youngest patients.

As neonatal intensive care continues to evolve, implementing these insights could transform prognostic frameworks and therapeutic pathways, attenuating the burden of AKI and preventing its grave sequelae. This landmark investigation serves as a clarion call to the medical community, advocating for heightened awareness, refined diagnostics, and integrated care approaches to confront one of the most insidious complications in neonatal HIE.

The intricate tapestry woven by brain and kidney injuries in newborns emerges more clearly from this research, demanding a nuanced understanding that transcends traditional boundaries. As the scientific and medical communities absorb these crucial findings, the hope for mitigating the devastating impact of hypoxic ischemic encephalopathy and its renal consequences shines brighter than ever.

Subject of Research: Risk factors and long-term outcomes of acute kidney injury in neonates with hypoxic ischemic encephalopathy

Article Title: Evaluation of risk factors and outcomes of neonates with hypoxic ischemic encephalopathy and acute kidney injury

Article References:

Todo Bom Costa, S., Costa Reis, P. & Mendes Graça, A. Evaluation of risk factors and outcomes of neonates with hypoxic ischemic encephalopathy and acute kidney injury.
J Perinatol (2025). https://doi.org/10.1038/s41372-025-02379-x

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41372-025-02379-x